During a mean follow-up of 7.8 years , 39 participants in the treatment group and 37 in the placebo group developed incident dementia ( hazard ratio ( HR ) = 1.11 , 95 % confidence interval ( CI ) = 0.71-1 .74 , P = .64 ) .
